Literature DB >> 21926155

Vascular function and morphology in rheumatoid arthritis: a systematic review.

Aamer Sandoo1, Jet J C S Veldhuijzen van Zanten, George S Metsios, Douglas Carroll, George D Kitas.   

Abstract

OBJECTIVES: RA associates with significantly increased morbidity and mortality from cardiovascular disease (CVD). This may be due to complex interactions between traditional CVD risk factors, systemic rheumatoid inflammation and the vasculature. We reviewed the current literature to answer: (i) whether there is sufficient evidence that patients with RA have altered vascular function and morphology compared with normal controls; (ii) whether there is sufficient evidence to determine if such changes relate predominantly to systemic inflammation; and (iii) whether any changes of vascular function and morphology in RA can be modified with therapy.
METHODS: The MEDLINE database was searched to identify publications from 1974 to 1 November 2010 pertaining to vascular function and morphology in RA. The total number of articles included in the present review was 93. This included 57 cross-sectional studies, 27 longitudinal studies without randomization and 9 longitudinal studies with randomization.
RESULTS: Vascular function and morphology was impaired in RA relative to healthy controls. The majority of studies reported no associations between systemic inflammation and vascular function. Treatment with anti-inflammatory medication resulted in both transient and long-term improvements in the vasculature, but only a few studies reported associations between change in inflammation and change in vascular function and morphology.
CONCLUSION: The link between systemic inflammation and vascular function and morphology is not wholly supported by the available literature. Long-term studies examining specific predictors (including CVD risk factors) on the vasculature in RA are needed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926155     DOI: 10.1093/rheumatology/ker275

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  50 in total

1.  Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model.

Authors:  Janina Willers; Andreas Hahn
Journal:  Rheumatol Int       Date:  2011-11-16       Impact factor: 2.631

2.  Preventing Heart Failure in Inflammatory and Immune Disorders.

Authors:  Maya Serhal; Chris T Longenecker
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-06

3.  Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors.

Authors:  Aikaterini Arida; Evi Zampeli; George Konstantonis; Kalliope Fragiadaki; George D Kitas; Athanasios D Protogerou; Petros P Sfikakis
Journal:  Clin Rheumatol       Date:  2015-03-11       Impact factor: 2.980

Review 4.  Managing premature atherosclerosis in patients with chronic inflammatory diseases.

Authors:  Alexandra Legge; John G Hanly
Journal:  CMAJ       Date:  2018-04-09       Impact factor: 8.262

5.  Comparison of the effects of exercise and anti-TNF treatment on cardiovascular health in rheumatoid arthritis: results from two controlled trials.

Authors:  Jet J C S Veldhuijzen van Zanten; Aamer Sandoo; George S Metsios; Antonios Stavropoulos-Kalinoglou; Nikos Ntoumanis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-11-12       Impact factor: 2.631

6.  Roles of microRNA-539 and osteopontin in rheumatoid arthritis.

Authors:  Yan Liu; Kai Qian; Chunmei Li; Yi Ma; Xingguo Chen
Journal:  Exp Ther Med       Date:  2017-12-21       Impact factor: 2.447

Review 7.  The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis.

Authors:  George S Metsios; R H Moe; M van der Esch; J J C S Veldhuijzen van Zanten; S A M Fenton; Y Koutedakis; P Vitalis; N Kennedy; N Brodin; C Bostrom; T W Swinnen; K Tzika; K Niedermann; E Nikiphorou; G E Fragoulis; T P V M Vlieland; C H M Van den Ende; George D Kitas
Journal:  Rheumatol Int       Date:  2019-12-04       Impact factor: 2.631

Review 8.  Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.

Authors:  Cristina Panico; Gianluigi Condorelli
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 9.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

10.  Improving cardiovascular health and metabolic comorbidities in patients with psoriatic arthritis.

Authors:  Alexis Ogdie; Lihi Eder
Journal:  Int J Clin Rheumtol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.